Phase III confirmatory

Related by string. * phases . Phases . phase . PHASE . PHASES : Phase III clinical trials . Phase III trials . Phase 2b clinical . pivotal Phase III . ongoing Phase 1b / Iii . iii . IIIs . IIID : Star Wars Episode III . Phase III clinical . Guitar Hero III . Tha Carter III / Confirmatory : confirmatory due diligence . initiated confirmatory Phase . confirmatory pivotal . confirmatory Phase III * *

Related by context. Frequent words. (Click for all words.) 74 confirmatory Phase III 70 phase IIa 69 Phase 1b clinical 68 Phase Ib clinical 68 Phase IIb clinical 68 Phase Ib 68 Phase 1b trial 67 double blinded placebo 67 Phase IIa clinical 67 Phase 2a trial 67 phase IIb 65 registrational 65 Phase 2b clinical 65 Pivotal Trial 65 phase 2a 64 Phase 2a 64 confirmatory Phase 3 64 Phase 2b study 64 Phase IIb 64 Phase 2a clinical 64 placebo controlled clinical 64 tezampanel 63 Phase III clinical 63 label multicenter 63 deforolimus 63 Phase III 63 Phase IIa trial 63 multicenter randomized double 63 KNS # 63 Phase 1b 62 TELCYTA 62 Phase 2b trial 62 Phase II 62 pivotal Phase III 62 Phase III pivotal 62 registrational trial 62 Pivotal Phase III 62 CCX# 62 Sym# 62 tanespimycin 62 randomized Phase III 62 pseudobulbar affect PBA 61 dose escalation trial 61 Vilazodone 61 MAP# 61 Phase 1a 61 ICA # 61 Phase Ia 61 ATL# [001] 61 BAY #-# 61 RSD# 61 Phase IIa 61 Zerenex 61 Pivotal Phase 61 elotuzumab 61 Synavive 61 Zelrix 61 Azedra 61 Phase IIb trial 60 Neurodex 60 MNTX 60 RGB # 60 multicenter clinical 60 Targretin 60 Anturol 60 Diamyd ® 60 PRECISE 60 Phase III Clinical Trial 60 methylnaltrexone 60 Phenoptin 60 unblinding 60 IND submission 60 romidepsin 60 Cethromycin 59 PROPEL trial 59 Cloretazine R VNP#M 59 Icatibant 59 Carfilzomib 59 BLA submission 59 Phase IIa clinical trials 59 Completes Enrollment 59 GV# [001] 59 SinuNase 59 Phase 2b 59 axitinib 59 SCH # 59 CA4P 59 PXD# 59 anticancer compound 59 ocrelizumab 59 multicenter randomized 59 ALN TTR# 59 IPX# 59 Pirfenidone 59 multiple ascending dose 59 mTOR inhibitor 59 pertuzumab 59 Allovectin 7 R 59 Investigational Device Exemption 59 Laquinimod 58 celgosivir

Back to home page